A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

NCT03191201 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The reason for early termination is difficulties recruiting that caused a premature ending of financial resources ensuring protected time for research.

Conditions

Iron-deficiency
Iron Toxicity
Glucose Metabolism Disorders (Including Diabetes Mellitus)
Metabolic Side Effects of Drugs
Metabolic Disorder, Glucose
Safety Issues

Interventions

DRUG: Ferric Carboxymaltose
DRUG: 0.9% sodium chloride solution

Sponsor

Prof Gérard WAEBER

Collaborators

[object Object]
[object Object]
[object Object]